Kaival Brands director granted 250K options
Kaival Brands Innovations Group, Inc. (KAVL) reported that director Mark L. Thoenes received a grant of 250,000 non-qualified stock options on August 15, 2026 under the Amended and Restated 2020 Stock and Incentive Compensation Plan.
Rhea-AI Filing Summary
Kaival Brands Innovations Group, Inc. (KAVL) reported that director Mark L. Thoenes received a grant of 250,000 non-qualified stock options on August 15, 2026 under the Amended and Restated 2020 Stock and Incentive Compensation Plan. The options have an exercise price of $0.0273 per share and now bring his reported option holdings to 750,000 options.
The award vests in full on the earlier of December 31, 2026 or a Change in Control, subject to his continued service as a director, and expires on August 15, 2036. No Rule 10b5-1 trading plan is reported for this grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) F1, F3, F2, F4 | 250,000 | $0.00 | $0.00 |
Footnotes (4)
- F1. Non-qualified stock option for 250,000 shares granted on August 15, 2026 under the Issuer's Amended and Restated 2020 Stock and Incentive Compensation Plan.
- F2. Vests in full on the earlier of December 31, 2026 or a Change in Control, subject to continued service as a director.
- F3. Exercise price equals Fair Market Value on the Grant Date.
- F4. Includes 500,000 options previously reported on the Form 4 filed April 7, 2026.
Key Figures
Key Terms
Non-Qualified Stock Option financial
Fair Market Value financial
Change in Control financial
Amended and Restated 2020 Stock and Incentive Compensation Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did KAVL disclose about director Mark L. Thoenes in this Form 4?
What are the key terms of the 250,000 KAVL stock options granted to Mark L. Thoenes?
How many KAVL options does Mark L. Thoenes hold after this transaction?
Was the KAVL option grant to Mark L. Thoenes made under a Rule 10b5-1 plan?
What is the vesting condition for the new KAVL options granted to Mark L. Thoenes?
AI-generated analysis. How Rhea-AI works. Not financial advice.